Search results for: 'DA0A-01'

The rapid expansion of Internet of Things (IoT) ecosystems has intensified the demand for uninterrupted, autonomous sensing solutions that can operate without reliance on conventional batteries. This research study investigates the evolving landscape of self-powered sensors as a foundational technology for next-generation, batteryless IoT—particula...

This Frost & Sullivan annual outlook analyzes the medical devices industry across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa. The study provides insights into market size, growth rates, opportunities, strategic imperatives, and macroeconomic trends shaping the medical devices industry. The study period spans 202...

Vital signs monitoring devices that support remote monitoring are growing rapidly due to the increasing need for home care and chronic disease management solutions. Moreover, the increasing workload on clinicians and nurses is driving demand for continuous vital signs monitoring solutions in hospital settings. Clinical-grade wearables are dominatin...

The SCOPE Summit 2026, held in Orlando, Florida, from February 2 to 5, 2026, highlighted the dominance of small- to mid-segment companies and specialized CROs focusing on specific therapy areas or aspects of clinical trials, such as bioanalysis. With more than 4,000 attendees, 630 speakers, and 300 exhibitors, SCOPE 2026 reinforced its position as ...

The report explores the transformation of obesity care from generalized BMI-based treatment to AI-enabled precision metabolic management. The study highlights how obesity is increasingly recognized as a heterogeneous, multi-pathway disease influenced by genetic, neurobehavioral, metabolic, and environmental factors, requiring personalized therapeut...

This research study evaluates the evolving global digital therapeutics (DTx) ecosystem, with a focused analysis on Cognitive DTx and Metabolic DTx. The study examines the transition of DTx from emerging digital health tools toward clinically validated, interoperable, and scalable therapeutic platforms integrated within broader healthcare ecosystems...

The capnography market is undergoing a significant transformation from its traditional role in anesthesia and intensive care monitoring to a broader, continuous respiratory surveillance ecosystem. This evolution is being driven by increasing integration of capnography into multiparameter monitoring platforms by original equipment manufacturers (OEM...

This research analyzes how point-of-care (PoC) diagnostics is evolving from simple tests to decentralized, connected, and clinically actionable testing platforms across hospitals, outpatient settings, homes, and pharmacies.The study assesses key technology shifts, including rapid molecular testing, lateral flow assays, microfluidics, biosensors, sm...

A digital biomarker refers to measurable data about physiological functions or behaviors collected through digital devices and technologies, such as wearables, implants, ingestible sensors, smartphones, and mobile applications. These biomarkers provide continuous, real-time insights into an individual’s health status and are used to monitor normal ...